Medicare for All is a viable solution to the U.S. healthcare crisis

A single-payer system could address rising medical costs and expand coverage to all Americans.

Overview Debates Related claims Topics Sources

Younger patients should receive priority when lifesaving treatment is scarce

Insurers should be barred from setting premiums using genetic tests

Competent adults should be allowed to sell a kidney

Publicly funded healthcare should cover infertility treatment

Medicare coverage of anti-obesity drugs would add about $35 billion to federal spending from 2026 to 2034

Semaglutide carries a regulator-confirmed risk of NAION, a very rare optic nerve condition

Semaglutide and tirzepatide are cost-effective for obesity at current net prices

Most adults with obesity but without diabetes stop GLP-1 drugs within a year

Medicare coverage of weight-loss drugs could save Medicare $175–245 billion over ten years

Placebo-controlled trials should be required before approving new medicines

New medicines should have to outperform existing treatments before approval

Governments should license publicly funded drug patents to competitors when prices are unaffordable

Medical research grants should be allocated by lottery among proposals that meet a quality threshold

Publicly funded medical research should be freely available immediately upon publication

Drugs for serious illnesses should qualify for accelerated approval based on biomarkers before patient benefit is proven

Terminally ill patients should be allowed experimental drugs before trials establish effectiveness

Public health systems should prioritize total health gains over treating the sickest first

Adults should be allowed attention-enhancing drugs even without a medical disorder

Psychedelics should be legal for therapeutic use

Healthcare should be free for everyone